Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive PCI for vulnerable coronary plaque (PREVENT)
NCT02316886Phase 4Completed
- Start
- Oct 2015
- Primary completion
- Oct 2023
- Countries
- 5
01
Overview
Phase 4, randomised, open-label trial in coronary artery disease (CAD) and atherosclerosis. Primary endpoint: Target vessel failure at 2 years. Started Oct 2015; status: completed.
02
Conditions
coronary artery disease (CAD)atherosclerosis
Beyond the preview
Go deeper on NCT02316886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02316886.